STORM EAGLE: Open Payments
NPI 1649607383 · MOORE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,752 in 90 payments from 24 companies in 2025. Trend: 2023 $1,420 · 2024 $1,407 · 2025 $1,752
Food & beverage: $1,752
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $392 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 16 | $261 |
| GlaxoSmithKline, LLC. | 17 | $206 |
| Paratek Pharmaceuticals, Inc. | 7 | $203 |
| Lilly USA, LLC | 5 | $102 |
| Novo Nordisk Inc | 5 | $91 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $65 |
| Medtronic, Inc. | 2 | $51 |
| Janssen Pharmaceuticals, Inc | 2 | $40 |
| Hikma Pharmaceuticals USA | 2 | $40 |
Products named: JARDIANCE, FARXIGA, NUZYRA, TRELEGY ELLIPTA, AIRSUPRA, MOUNJARO, Ozempic, XIFAXAN.
Industry payments across OK — which companies pay providers there.
